Invest Ophthalmol Vis Sci 1995;36:745-750
Similar content being viewed by others Introduction Amid the continuously increasing global incidence of diabetes, glucagon-like peptide-1 receptor agonists (GLP-1RAs) have emerged as a cornerstone in type 2 diabetes treatment, demonstrating remarkable efficacy in glycemic control and cardiovascular risk reduction [1, 2]
These injections aim to enhance liver function, boost metabolism, and promote fat loss
By contrast, peptides represent a more targeted solution: one molecule, one main effect
Further clinical evaluation (e.g., rheumatology referral) may be appropriate for patients who develop signs or symptoms of peripheral vasculopathy
Asthma Sensitivity: There have been reports that inhaled versions of glutathione (nebulized) can trigger issues for people with sensitive airways